InsidersTradesSigma
Explore the complete record of transactions filed by Halstead Michael, Vice-Président Exécutif. Director active across 1 companies, notably Intra-Cellular Therapies, Inc.. Cumulatively, 6 filings have been published. The latest transaction was disclosed on 21 December 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
6 of 6 declarations
Michael Halstead is Executive Vice President and General Counsel at Intra-Cellular Therapies, Inc. He is responsible for the company's legal affairs and compliance. His role is essential in navigating the complex regulatory landscape of the biopharmaceutical sector.